Clinical Trial

Research Platform Myelofibrosis and Anemia

Study acronym: RHODOLITE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor research platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease and to collect patient-reported outcomes for patients with primary and secondary myelofibrosis and anemia in Germany.
Protocol Amendment History 1 change
critical Recruitment opened 2026-03-31
Trial Details
NCT Number NCT06976918
Lead Sponsor iOMEDICO AG
Collaborators: German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
Conditions Primary Myelofibrosis, Secondary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Anemia, Myelofibrosis; Anemia, Myelofibrosis
Enrollment 200 participants
Start Date 2026-02-19
Primary Completion 2031-09 (estimated)
Study Completion 2031-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-05